BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 10564558)

  • 41. Differences in predominant T cell phenotypes and distribution pattern in reactional lesions of tuberculoid and lepromatous leprosy.
    Narayanan RB; Laal S; Sharma AK; Bhutani LK; Nath I
    Clin Exp Immunol; 1984 Mar; 55(3):623-8. PubMed ID: 6423326
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cytokine messenger RNA expression in chronic inflammatory periodontal disease.
    Yamazaki K; Nakajima T; Kubota Y; Gemmell E; Seymour GJ; Hara K
    Oral Microbiol Immunol; 1997 Oct; 12(5):281-7. PubMed ID: 9467381
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In situ and in vitro characterization of the cellular immune response in erythema nodosum leprosum.
    Modlin RL; Mehra V; Jordan R; Bloom BR; Rea TH
    J Immunol; 1986 Feb; 136(3):883-6. PubMed ID: 2416837
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Th1 predominance and perforin expression in minor salivary glands from patients with primary Sjögren's syndrome.
    Kolkowski EC; Reth P; Pelusa F; Bosch J; Pujol-Borrell R; Coll J; Jaraquemada D
    J Autoimmun; 1999 Aug; 13(1):155-62. PubMed ID: 10441181
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serum levels of tumour necrosis factor-alpha and interleukin-1 beta during leprosy reactional states.
    Sarno EN; Grau GE; Vieira LM; Nery JA
    Clin Exp Immunol; 1991 Apr; 84(1):103-8. PubMed ID: 2015700
    [TBL] [Abstract][Full Text] [Related]  

  • 46. alpha1-acid glycoprotein as a putative biomarker for monitoring the development of the type II reactional stage of leprosy.
    Gupta N; Shankernarayan NP; Dharmalingam K
    J Med Microbiol; 2010 Apr; 59(Pt 4):400-407. PubMed ID: 20075114
    [TBL] [Abstract][Full Text] [Related]  

  • 47. IL-18 up-regulates perforin-mediated NK activity without increasing perforin messenger RNA expression by binding to constitutively expressed IL-18 receptor.
    Hyodo Y; Matsui K; Hayashi N; Tsutsui H; Kashiwamura S; Yamauchi H; Hiroishi K; Takeda K; Tagawa Y; Iwakura Y; Kayagaki N; Kurimoto M; Okamura H; Hada T; Yagita H; Akira S; Nakanishi K; Higashino K
    J Immunol; 1999 Feb; 162(3):1662-8. PubMed ID: 9973427
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cytokine and cytotoxic molecule gene expression determined in peripheral blood mononuclear cells in the diagnosis of acute renal rejection.
    Dugré FJ; Gaudreau S; Belles-Isles M; Houde I; Roy R
    Transplantation; 2000 Oct; 70(7):1074-80. PubMed ID: 11045645
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differential production of interleukin-10 and interleukin-12 in mononuclear cells from leprosy patients with a Toll-like receptor 2 mutation.
    Kang TJ; Yeum CE; Kim BC; You EY; Chae GT
    Immunology; 2004 Aug; 112(4):674-80. PubMed ID: 15270740
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Increased serum levels of interleukin-6 in erythema nodosum leprosum suggest its use as a biomarker.
    Vilani-Moreno FR; Brito-de-Souza VN; Silva SMUR; Barbosa ASAA; Sartori BGC; Campanelli AP; Barreto JA; Virmond MDCL
    Indian J Dermatol Venereol Leprol; 2021; 87(2):190-198. PubMed ID: 33769734
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The recurrence of leprosy reactional episodes could be associated with oral chronic infections and expression of serum IL-1, TNF-alpha, IL-6, IFN-gamma and IL-10.
    Motta AC; Furini RB; Simão JC; Ferreira MA; Komesu MC; Foss NT
    Braz Dent J; 2010; 21(2):158-64. PubMed ID: 20640364
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synovial fluid T cell clones from oligoarticular juvenile arthritis patients display a prevalent Th1/Th0-type pattern of cytokine secretion irrespective of immunophenotype.
    Gattorno M; Facchetti P; Ghiotto F; Vignola S; Buoncompagni A; Prigione I; Picco P; Pistoia V
    Clin Exp Immunol; 1997 Jul; 109(1):4-11. PubMed ID: 9218817
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differential Expression of IFN-
    Antunes DE; Goulart IMB; Lima MIS; Alves PT; Tavares PCB; Goulart LR
    J Immunol Res; 2019; 2019():3405103. PubMed ID: 31781675
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Susceptibility to Mycobacterium leprae of ALY (alymphoplasia) mice and IFN-gamma induction in the culture supernatant of spleen cells.
    Yogi Y; Endoh M; Banba T; Okamura H; Nomaguchi H
    Int J Lepr Other Mycobact Dis; 1998 Dec; 66(4):464-74. PubMed ID: 10347567
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunological cytokine correlates of protective immunity and pathogenesis in leprosy.
    Lima MC; Pereira GM; Rumjanek FD; Gomes HM; Duppre N; Sampaio EP; Alvim IM; Nery JA; Sarno EN; Pessolani MC
    Scand J Immunol; 2000 Apr; 51(4):419-28. PubMed ID: 10736116
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Early molecular events in the induction phase of contact sensitivity.
    Enk AH; Katz SI
    Proc Natl Acad Sci U S A; 1992 Feb; 89(4):1398-402. PubMed ID: 1741395
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reactional states in multibacillary Hansen disease patients during multidrug therapy.
    Nery JA; Vieira LM; de Matos HJ; Gallo ME; Sarno EN
    Rev Inst Med Trop Sao Paulo; 1998; 40(6):363-70. PubMed ID: 10436656
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differential TNFalpha mRNA regulation detected in the epidermis of leprosy patients.
    Teles RM; Moraes MO; Geraldo NT; Salles AM; Sarno EN; Sampaio EP
    Arch Dermatol Res; 2002 Nov; 294(8):355-62. PubMed ID: 12420104
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression of CD64 on Circulating Neutrophils Favoring Systemic Inflammatory Status in Erythema Nodosum Leprosum.
    Schmitz V; Prata RB; Barbosa MG; Mendes MA; Brandão SS; Amadeu TP; Rodrigues LS; Ferreira H; Costa Fda M; Dos Santos JB; Pacheco Fdos S; Machado Ade M; Nery JA; Hacker Mde A; Sales AM; Pinheiro RO; Sarno EN
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004955. PubMed ID: 27556927
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Whole blood profiling of leprosy type 1(reversal) reactions highlights prominence of innate immune response genes.
    Rêgo JL; de Lima Santana N; Machado PRL; Ribeiro-Alves M; de Toledo-Pinto TG; Castellucci LC; Moraes MO
    BMC Infect Dis; 2018 Aug; 18(1):422. PubMed ID: 30143000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.